Response to vaccination against SARS‐CoV ‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue British Journal of Haematology Année : 2022

Response to vaccination against SARS‐CoV ‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study

Domaines

Hématologie
Fichier non déposé

Dates et versions

hal-03737660 , version 1 (25-07-2022)

Identifiants

Citer

Olivier Tournilhac. Response to vaccination against SARS‐CoV ‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study. British Journal of Haematology, 2022, 197 (4), pp.424-427. ⟨10.1111/bjh.18055⟩. ⟨hal-03737660⟩
21 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More